NCT01775930
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Carcinoma, Renal Cell
Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.
1,363 public trials
252 recruiting studies
Carcinoma, Renal Cell trial results
NCT02014636
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Novartis Investigative Site Boston, Massachusetts, United States
- Novartis Investigative Site Boston, Massachusetts, United States
- Novartis Investigative Site New York, United States
- Novartis Investigative Site Nashville, Tennessee, United States
NCT02060370
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Stanford University Medical Center Stanford, California, United States
- Lineberger Cancer Center Chapel Hill, North Carolina, United States
- Cleveland Clinic Taussig Cancer Institute Cleveland, Ohio, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
NCT00749320
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT02645409
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Indiana University Health Hospital Indianapolis, Indiana, United States
- Indiana University Health Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
Completed
MRI in Renal Tumors
NCT02325921
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Radboud University Medical Center Nijmegen, Netherlands
NCT01497444
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +20 more
- Locations
-
- Mayo Clinic Scottsdale Scottsdale, Arizona, United States
- Mayo Clinic Cancer Center Rochester, Minnesota, United States
NCT01846520
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +137 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Completed
Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer
NCT01065441
- Conditions
- Adenocarcinoma, Adnexal Diseases, Breast Cancer, +62 more
- Locations
-
- Hadassah-Hebrew University Medical Center Jerusalem, Israel
- Conditions
- Acute Undifferentiated Leukemia, Adenocarcinoma, Adult Nasal Type Extranodal NK/T-cell Lymphoma, +152 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
- University of Torino Torino, Italy